우리나라 갑상선암의 발생 현황 및 특징
Incidence and clinical characteristics of thyroid cancer in Korea
1
조회
0
다운로드
16
인용
0
참고문헌
키워드
초록
The incidence of thyroid cancer is steadily increasing in many countries including Korea. Especially in Korea, the incidence of thyroid cancer is very rapidly increasing during several decades; from 2005 Annual Report of the Korea Center Cancer Registry, thyroid cancer ranked the fifth among all cancers (incidence rate was 8.9%). Moreover the incidence of thyroid cancer was 16.7% in female and now thyroid cancer was reported the most common cancer in Korean female. Among several thyroid cancers, papillary thyroid cancer (PTC) is rapidly increasing due to the increased detection of papillary thyroid microcarcinoma (PMC). Until now, PMC showed little significant differences among clinical characteristics or prognosis compared with PTC, thus the optimal treatment strategy of PMC remains controversial. Therefore, to establish the optimal treatment and follow up program about thyroid cancer, we should investigate clinical characteristics, prognosis and predictive factors of PMC more closely.
참고문헌 (23)
- Liu S, "Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period- cohort effects", Br J Cancer, 85, pp.1335~1339 (2001)
- Kilfoy BA, "International patterns and trends in thyroid cancer incidence, 1973-2002", Cancer Causes Control, 20, pp.525~531 (2009)
- Leenhardt L, "Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee", Thyroid, 14, pp.1056~1060 (2004)
- Reynolds RM, "Changing trends in incidence and mortality of thyroid cancer in Scotland", Clin Endocrinol, 62, pp.156~162 (2005)
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295, pp.2164~2167 (2006)
- 국가암등록사업 연례 보고서 (2005년 암발생, 1993~2005년 암생존 현황), , ~ (2008)
- 김경희, "Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population", Yonsei Medical Journal, 45(5), pp.818~821 (2004), 연세대학교의과대학
- Tan GH, "Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging", Ann Intern Med, 126, pp.226~231 (1997)
- Dean DS, "Epidemiology of thyroid nodules", Best Pract Res Clin Endocrinol Metab, 22, pp.901~911 (2008)
- Papini E, "Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87, pp.1941~1946 (2002)
- Hagag P, "Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules", Thyroid, 8, pp.989~995 (1998)
- 석지혜, "갑상선 질환의 기왕력이 없는 성인에서 갑상선 초음파 선별검사로 발견된 갑상선 결절의 유병률", 대한내분비학회지, 21(5), pp.389~393 (2006), 대한내분비학회
- 김원준, "건강검진 수진 성인에게서 초음파로 발견된 갑상선 결절 유병률과 미세침흡인세포검사 결과", 대한내분비학회지, 23(6), pp.413~419 (2008), 대한내분비학회
- Nam-Goong IS, "Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings", Clin Endocrinol, 60, pp.21~28 (2004)
- 이승훈, "1개 병원 갑상선 암환자 특성의 추이 분석", 대한내분비학회지, 23(1), pp.35~43 (2008), 대한내분비학회
- Lee J, "Frequent, aggressive behaviors of thyroid microcarcinomas in Korean patients", Endocr J, 53, pp.627~632 (2006)
- Park YJ, "Papillary microcarcimoma in comparison with larger papillary thyroid carcinoma in BRAF (V600E) mutation, clinicopathological features, and immunohistochemical findings", Head Neck (2009)
- Xing M, "BRAF mutation in thyroid cancer", Endocr Relat Cancer, 12, pp.245~262 (2005)
- Xing M, "BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer", J Clin Endocrinol Metab, 90, pp.6373~6379 (2005)
- Jo YS, "Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer", J Clin Endocrinol Metab, 91, pp.3667~3670 (2006)
- Lee JH, "BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas", Pathology, 38, pp.201~204 (2006)
- Kim TY, "The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma", Clin Endocrinol, 63, pp.588~593 (2005)
- Kim TY, "The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma", Clin Endocrinol, 65, pp.364~368 (2006)